SECOND AMENDED AND RESTATED 10% CONVERTIBLE DEBENTURE DUE OCTOBER 1, 2022G Medical Innovations Holdings Ltd. • October 27th, 2022 • Surgical & medical instruments & apparatus • New York
Company FiledOctober 27th, 2022 Industry JurisdictionTHIS SECOND AMENDED AND RESTATED 10% CONVERTIBLE DEBENTURE (this “Debenture”) amends and restates that certain 10% Convertible Debenture, originally dated April 7, 2021, as amended and restated on June 1, 2022, which was one of a series of duly authorized and validly issued 10% Convertible Debentures of G Medical Innovations Holdings Ltd., a Cayman Islands exempted company (the “Company”), having its principal place of business at 5 Oppenheimer St., Rehovot 7670105, Israel, designated as its 10% Convertible Debenture due October 7, 2021 (this Debenture, collectively with the other debentures of such original October 2021 series, the “Debentures”).
AMENDED AND RESTATED 10% CONVERTIBLE DEBENTURE DUE October 7, 2022G Medical Innovations Holdings Ltd. • July 11th, 2022 • Surgical & medical instruments & apparatus • New York
Company FiledJuly 11th, 2022 Industry JurisdictionTHIS AMENDED AND RESTATED 10% CONVERTIBLE DEBENTURE (this “Debenture”) amends and restates that certain 10% Convertible Debenture, originally dated April 7, 2021 (the “Original Debenture”), which was one of a series of duly authorized and validly issued 10% Convertible Debentures of G Medical Innovations Holdings Ltd., a Cayman Islands corporation (the “Company”), having its principal place of business at 5 Oppenheimer St., Rehovot 7670105, Israel, designated as its 10% Convertible Debenture due October 7, 2021 (this Debenture, collectively with the other debentures of such original October 2021 series, the “Debentures”).
10% CONVERTIBLE DEBENTURE DUE October 7, 2021G Medical Innovations Holdings Ltd. • April 22nd, 2021 • Surgical & medical instruments & apparatus • New York
Company FiledApril 22nd, 2021 Industry JurisdictionTHIS 10% CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued 10% Convertible Debentures of G Medical Innovations Holdings Ltd., a Cayman Islands corporation (the “Company”), having its principal place of business at 5 Oppenheimer St., Rehovot 7670105, Israel, designated as its 10% Convertible Debenture due October 7, 2021 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
10% CONVERTIBLE DEBENTURE DUE August 21, 2021G Medical Innovations Holdings Ltd. • March 4th, 2021 • Surgical & medical instruments & apparatus • New York
Company FiledMarch 4th, 2021 Industry JurisdictionTHIS 10% CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued 10% Convertible Debentures of G Medical Innovations Holdings Ltd., a Cayman Islands corporation (the “Company”), having its principal place of business at 5 Oppenheimer St., Rehovot 7670105, Israel, designated as its 10% Convertible Debenture due June 21, 2021 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
10% CONVERTIBLE DEBENTURE DUE June 21, 2021G Medical Innovations Holdings Ltd. • March 4th, 2021 • Surgical & medical instruments & apparatus • New York
Company FiledMarch 4th, 2021 Industry JurisdictionTHIS 10% CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued 10% Convertible Debentures of G Medical Innovations Holdings Ltd., a Cayman Islands corporation (the “Company”), having its principal place of business at 5 Oppenheimer St., Rehovot 7670105, Israel, designated as its 10% Convertible Debenture due June 21, 2021 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
10% CONVERTIBLE DEBENTURE DUE June 21, 2021G Medical Innovations Holdings Ltd. • February 23rd, 2021 • Surgical & medical instruments & apparatus • New York
Company FiledFebruary 23rd, 2021 Industry JurisdictionTHIS 10% CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued 10% Convertible Debentures of G Medical Innovations Holdings Ltd., a Cayman Islands corporation (the “Company”), having its principal place of business at 5 Oppenheimer St., Rehovot 7670105, Israel, designated as its 10% Convertible Debenture due June 21, 2021 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).
10% CONVERTIBLE DEBENTURE DUE June 21, 2021G Medical Innovations Holdings Ltd. • January 13th, 2021 • Surgical & medical instruments & apparatus • New York
Company FiledJanuary 13th, 2021 Industry JurisdictionTHIS 10% CONVERTIBLE DEBENTURE is one of a series of duly authorized and validly issued 10% Convertible Debentures of G Medical Innovations Holdings Ltd., a Cayman Islands corporation (the “Company”), having its principal place of business at 5 Oppenheimer St., Rehovot 7670105, Israel, designated as its 10% Convertible Debenture due June 21, 2021 (this debenture, the “Debenture” and, collectively with the other debentures of such series, the “Debentures”).